Medpace Holdings, Inc.

Medpace Holdings, Inc.

MEDP·NASDAQ

$450.81

+1.2%
HealthcareMedical - Diagnostics & Research

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The company was founded in 1992 and is based in Cincinnati, Ohio.

At a Glance

Live Snapshot
Market Cap$12.88B
EPS15.6400
P/E Ratio28.82
Earnings Date07/20/2026

medp

Shares Outstanding

Last Annual Value

29.53M

3-Year CAGR

-4%

5-Year CAGR

-5%

10-Year CAGR

-3%

Medpace Holdings, Inc.

Medpace Holdings, Inc. Competitors Analysis of shares-outstanding

MEDP · NASDAQ
Companyshares-outstanding
CAGR 3Y
CAGR 5Y
CAGR 10Y
29.53M
-2.5%-4.8%-2.1% 
491.07M
-3.5%-3.6%4.1%
TEM logo
Tempus AI, Inc.
NASDAQ:TEM
174.26M
4.2%0.5%N/A
59.71M
0.2%-0.8%-3.1%
113.00M
0.0%-2.5%-2.3%
ILMN logo
Illumina, Inc.
NASDAQ:ILMN
156.00M
-0.4%0.7%0.5%
72.70M
-1.2%-1.0%-0.3%
90.83M
-4.7%-3.5%-0.9%
HOLX logo
Hologic, Inc.
NASDAQ:HOLX
227.57M
-2.9%-2.6%-2.3%
Medpace Holdings, Inc.

Medpace Holdings, Inc. Fair Value Envelope

MEDP · NASDAQ

Our analysis suggests that MEDP has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $450.815, this represents a potential HIDDEN relative to our calculated worth for Medpace Holdings, Inc..

Intrinsic Value
Current Price: $450.815